Cargando…
Medications and the Risk of Colorectal Cancer in Patients with Inflammatory Bowel Diseases: Use of the Landmark Method
PURPOSE: This study aimed to determine whether the use of drugs in the treatment of inflammatory bowel disease is related to the risk of colorectal cancer using a Cox proportional hazards model with the landmark method to minimize immortal time bias. MATERIALS AND METHODS: This study was conducted a...
Autores principales: | Choi, Yoon Young, Lee, Jung Kuk, Kim, Hyun-Soo, Kim, Dong Wook, Kim, Hee Man, Kang, Dae Ryong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Yonsei University College of Medicine
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8542472/ https://www.ncbi.nlm.nih.gov/pubmed/34672133 http://dx.doi.org/10.3349/ymj.2021.62.11.997 |
Ejemplares similares
-
Venous Thromboembolism Risk in Asian Patients with Inflammatory Bowel Disease: A Population-Based Nationwide Inception Cohort Study
por: Kim, Su Young, et al.
Publicado: (2022) -
Incident Crohn’s Disease as a Risk Factor for Colorectal Cancer in the First 10 Years after Diagnosis: A Nationwide Population-Based Study
por: Kim, Hyunil, et al.
Publicado: (2021) -
Risk of Gastric Cancer among Patients with Newly Diagnosed Ulcerative Colitis: A Nationwide Population-Based Study
por: Kim, Hee Man, et al.
Publicado: (2023) -
Colonoscopy Versus Fecal Immunochemical Test for Reducing Colorectal Cancer Risk: A Population-Based Case–Control Study
por: Kim, Su Young, et al.
Publicado: (2021) -
Robotic Colorectal Surgery: Is It Still on the Way to a Landmark?
por: Kim, Nam Kyu
Publicado: (2012)